Takeda Pharma AG - Equasym XR 30 mg; Retardkapseln | | 57295 | | 03 | | Equasym XR 30 mg; Retardkapseln | | | | N06BA04 | | Methylphenidat | | 12.03.2010 | | |
| Composition | methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 102.3-149.8 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, Kapselhülle: gelatina, E 132, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, E 171, E 172 (nigrum) pro capsula. | Packungsbestandteile | Principe actif | Concentr. |
---|
Methylphenidate Hydrochloride | 30 mg |
| BAG: Principe actif | Concentr. |
---|
Methylphenidate Hydrochloride | 30 mg |
| Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) pro Capsula | | | (Rubrum) | | | Ammoniae Solutio | 28 | | Dibutylis Sebacas | | | E 132 | | color. | E 171 | | color. | E 172 | | color. | Ethylcellulosum | | | Gelatina | | Kapselhülle | Hypromellosum | | | Lacca | | Drucktinte | Macrogola | | | Maydis Amylum | | | Sodium Hydroxide | | | Per Centum | | | Povidone | | | Propylenglycol | | | Sacchari Sphaerae | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
Aucune entrée n'a été trouvée. |
|
|